WallStreetZenWallStreetZen

NASDAQ: HROW
Harrow Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HROW

Based on 3 analysts offering 12 month price targets for Harrow Inc

Min Forecast
$45.00+67.35%
Avg Forecast
$65.33+142.96%
Max Forecast
$88.00+227.26%

Should I buy or sell HROW stock?

Based on 3 analysts offering ratings for Harrow Inc.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although HROW's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates HROW as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their HROW stock forecasts and price targets.

HROW stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-10-07
lockedlocked$00.00+00.00%2026-09-09
lockedlocked$00.00+00.00%2026-05-13

1 of 1

Forecast return on equity

Is HROW forecast to generate an efficient return?

Company
N/A
Industry
145.98%
Market
167.36%

Forecast return on assets

Is HROW forecast to generate an efficient return on assets?

Company
N/A
Industry
21.96%

HROW earnings per share forecast

What is HROW's earnings per share in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
-$0.20
Avg 2 year Forecast
$2.41
Avg 3 year Forecast
$4.02

HROW revenue forecast

What is HROW's revenue in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$357.2M+29.6%
Avg 2 year Forecast
$545.9M+98.08%
Avg 3 year Forecast
$731.1M+165.3%
HROW's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HROW revenue growth forecast

How is HROW forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
38.49%
Industry
7.82%
Market
12.09%
HROW's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HROW's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HROW vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
HROW$26.89$65.33+142.96%Strong Buy
AMPH$28.49$22.00-22.78%Hold
COLL$24.21$44.00+81.74%Buy
IRWD$4.39N/AN/A
CRON$3.61N/AN/AStrong Buy
View Top Pharmaceutical Stocks

Harrow Stock Forecast FAQ

Is Harrow Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: HROW) stock is to Strong Buy HROW stock.

Out of 3 analysts, 2 (66.67%) are recommending HROW as a Strong Buy, 1 (33.33%) are recommending HROW as a Buy, 0 (0%) are recommending HROW as a Hold, 0 (0%) are recommending HROW as a Sell, and 0 (0%) are recommending HROW as a Strong Sell.

If you're new to stock investing, here's how to buy Harrow stock.

What is HROW's earnings growth forecast for 2026-2028?

(NASDAQ: HROW) Harrow's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 12.66%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.04%.

Harrow's earnings in 2026 is -$37,226,000.On average, 11 Wall Street analysts forecast HROW's earnings for 2026 to be -$7,430,092, with the lowest HROW earnings forecast at -$20,940,713, and the highest HROW earnings forecast at $2,361,735. On average, 11 Wall Street analysts forecast HROW's earnings for 2027 to be $90,338,221, with the lowest HROW earnings forecast at $52,168,092, and the highest HROW earnings forecast at $149,970,144.

In 2028, HROW is forecast to generate $150,656,172 in earnings, with the lowest earnings forecast at $101,397,137 and the highest earnings forecast at $210,981,620.

What is HROW's revenue growth forecast for 2026-2028?

(NASDAQ: HROW) Harrow's forecast annual revenue growth rate of 38.49% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 7.82%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.09%.

Harrow's revenue in 2026 is $275,594,000.On average, 11 Wall Street analysts forecast HROW's revenue for 2026 to be $13,389,910,263, with the lowest HROW revenue forecast at $12,527,689,713, and the highest HROW revenue forecast at $13,974,720,723. On average, 11 Wall Street analysts forecast HROW's revenue for 2027 to be $20,464,617,315, with the lowest HROW revenue forecast at $17,597,546,547, and the highest HROW revenue forecast at $22,712,013,923.

In 2028, HROW is forecast to generate $27,408,866,649 in revenue, with the lowest revenue forecast at $24,127,930,017 and the highest revenue forecast at $30,932,724,549.

What is HROW's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: HROW) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 21.96%.

What is HROW's Price Target?

According to 3 Wall Street analysts that have issued a 1 year HROW price target, the average HROW price target is $65.33, with the highest HROW stock price forecast at $88.00 and the lowest HROW stock price forecast at $45.00.

On average, Wall Street analysts predict that Harrow's share price could reach $65.33 by Oct 7, 2027. The average Harrow stock price prediction forecasts a potential upside of 142.96% from the current HROW share price of $26.89.

What is HROW's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: HROW) Harrow's current Earnings Per Share (EPS) is -$0.99. On average, analysts forecast that HROW's EPS will be -$0.20 for 2026, with the lowest EPS forecast at -$0.56, and the highest EPS forecast at $0.06. On average, analysts forecast that HROW's EPS will be $2.41 for 2027, with the lowest EPS forecast at $1.39, and the highest EPS forecast at $4.00. In 2028, HROW's EPS is forecast to hit $4.02 (min: $2.70, max: $5.63).

What is HROW's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: HROW) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.